Application of resveratrol

Abstract

The invention discloses application of resveratrol in the preparation of a drug for treating endometrial cancer. Experiments prove that when the dosage of the resveratrol is 800mg / kg, the resveratrol is capable of obviously inhibiting the development of the cancer of a mouse with the endometrial cancer, has no obvious influence to the body weight of the mouse and has no obvious toxicity to organs of the mouse, so that the resveratrol is low in toxic and side effects and can be applied to the preparation of the drug for treating the endometrial cancer; and the application field of the resveratrol is exploited, and the resveratrol has good anti-tumor activity, low toxic and side effects and obvious social benefits.

Description

technical field

[0001] The invention relates to an application of resveratrol. Background technique

[0002] Endometrial cancer (EC) is one of the most common gynecological tumors, the fourth most common cancer in gynecological cancers in developed countries such as Europe and North America, and the sixth most common cancer in the world. In recent years, the incidence of EC in my country has also increased year by year, and the age of onset is getting younger and younger. The proportion of women younger than 40 years old in EC patients has reached 15%, and 70% of them have not given birth. Although surgery combined with radiotherapy and chemotherapy can achieve a good therapeutic effect, the loss of postoperative reproductive function and the risk of recurrence caused by conservative treatment still pose a serious threat to the physical and mental health of EC patients. Compared with other cancers, the biggest feature of EC is that its occurrence and development are closely...

Images